Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

Trust Insurance, one of Cyprus’ most established and trusted insurance providers, has announced the expansion of its health insurance services across the island, aiming to make private healthcare ...

Nigeria has taken a step towards digitising its overstretched agricultural extension system by validating a proposed ...

Over the past two years, Generative AI (GenAI) has captured global attention, including here in Kenya, thanks to its ability to draft content, summarise reports ...

There are 5 built-in tools in Windows 11/10 that can give you information about your system: Control Panel Computer Management SystemInfo MSInfo Utility Windows Settings. let us take a look at them in ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...

Neuroinflammation is associated with a wide spectrum of acute and chronic diseases of the central and peripheral nervous system. It causes secondary damage, which is a major determinant for ...

Long Covid patients face ongoing issues like tiredness and difficulty breathing. Researchers from the University of Zurich and University Hospital Zurich found that the complement system, a part of ...

Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of ...